KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gilead Sciences (GILD) Other Non-Current Liabilities (2016 - 2025)

Historic Other Non-Current Liabilities for Gilead Sciences (GILD) over the last 17 years, with Q3 2025 value amounting to $1.2 billion.

  • Gilead Sciences' Other Non-Current Liabilities fell 1532.95% to $1.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 billion, marking a year-over-year decrease of 1532.95%. This contributed to the annual value of $1.3 billion for FY2024, which is 3648.85% down from last year.
  • Per Gilead Sciences' latest filing, its Other Non-Current Liabilities stood at $1.2 billion for Q3 2025, which was down 1532.95% from $1.3 billion recorded in Q2 2025.
  • Gilead Sciences' 5-year Other Non-Current Liabilities high stood at $5.0 billion for Q1 2021, and its period low was $1.2 billion during Q3 2025.
  • Moreover, its 5-year median value for Other Non-Current Liabilities was $2.6 billion (2023), whereas its average is $2.9 billion.
  • Per our database at Business Quant, Gilead Sciences' Other Non-Current Liabilities plummeted by 455.99% in 2022 and then tumbled by 4793.16% in 2023.
  • Gilead Sciences' Other Non-Current Liabilities (Quarter) stood at $4.8 billion in 2021, then fell by 17.85% to $3.9 billion in 2022, then plummeted by 47.93% to $2.0 billion in 2023, then crashed by 36.49% to $1.3 billion in 2024, then dropped by 8.73% to $1.2 billion in 2025.
  • Its Other Non-Current Liabilities was $1.2 billion in Q3 2025, compared to $1.3 billion in Q2 2025 and $1.3 billion in Q1 2025.